Immuneed
PrivateLast Round
Corporate Funding
Oct 6, 2021
Total Funding Raised
$507,400
Company Overview
Immuneed operates in Healthcare & Life Sciences and is based in Uppsala. Its latest recorded funding round was a Corporate Funding round in October 2021.
Immuneed is a biotechnology company that operates a contract research organization providing preclinical drug development services using a proprietary human whole-blood assay platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Immuneed Comparables
Compare Immuneed with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alcyomics | 86% | |
| Explicyte Immuno-Oncology | 85% | |
| Celentyx Ltd | 84% |
For institutional investors. Book with your work email.
Immuneed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Oct 6, 2021 | ||||
| Seed | Sep 13, 2016 | ||||
| Grant | Jun 13, 2014 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Immuneed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Almi Invest AB | Seed |
| NWO Domain Applied and Engineering Sciences (AES) | Grant |
| Bio-X Accelerate Program | Grant |
| Uppsala University Invest | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 6, 2021
Raised a corporate funding round.
- Sep 13, 2016
$507K raised from Almi Invest AB and Uppsala University Invest.
For institutional investors. Book with your work email.
Immuneed Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Immuneed's valuation, stock price, and market status.
Is Immuneed a public or private company?
Immuneed is a private company.
What is the current stock price of Immuneed?
Immuneed is a private company, so its shares have no public market price. Caplight tracks Immuneed's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Immuneed worth (valuation)?
Valuation information for Immuneed is not publicly available.
Can I buy Immuneed stock?
Immuneed shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Immuneed's last funding round?
Immuneed's most recent funding round was Corporate Funding on October 6, 2021.
Who are the main investors in Immuneed?
Key investors in Immuneed include Almi Invest AB, NWO Domain Applied and Engineering Sciences (AES), Bio-X Accelerate Program, Uppsala University Invest.
Will Immuneed IPO soon?
No public IPO plans have been announced for Immuneed.
How can I track Immuneed secondary market activity?
Caplight tracks bids, offers, and trades in Immuneed's shares on secondary markets.